Capex / revenue moved 1479 bp higher
Capex / revenue changed +1479 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
12.08%→26.87%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GEVO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 38260 bp lower
Operating margin changed -38260 basis points from the comparable as-filed period.
13.35%→-369.25%3 prior comparisons
Shares outstanding increased 2.2%
Shares outstanding changed +2.2% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
241,839,083→247,237,1047 prior comparisons
Current long-term debt decreased 100.0%
Current long-term debt changed -100.0% from the comparable as-filed period.
$27.9M→$03 prior comparisons
Research & development decreased 52.9%
Research & development changed -52.9% from the comparable as-filed period.
$934,000→$440,0003 prior comparisons
Current liabilities decreased 48.6%
Current liabilities changed -48.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$73.2M→$37.6M4 prior comparisons
Current assets decreased 40.4%
Current assets changed -40.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$170.4M→$101.6M4 prior comparisons
Working capital decreased 34.2%
Working capital changed -34.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$97.2M→$64.0M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.